The research proposal for the original P4O2 project has been submitted to the Match call of Health~Holland, an organization that supports public private collaboration, in March 2020. More information regarding this call can be found here. The proposal was assessed by the LSH Evaluation Committee. The comments were good and we were invited to resubmit the project with a complete budget in October 2020. Parts of the proposal will be financed by the different universities via the ‘Grondslagen’, and the researchers will contribute a large amount of their time in-kind.
The COVID-19 extension of P4O2 has been provisionally accepted by Health~Holland. The consortium agreement for both the original P4O2 plan as for the COVID extension is getting signed by the 24 partners joining the consortium. Once the consortium agreement is signed, the COVID extension can officially start. It will also strengthen the re-application of the original project in October 2020.
In the last year we contacted various organizations with a flyer and a brochure about the original P4O2 project proposal. On the 17th of September 2019 a meeting was organized for potentially interested parties to learn all about joining a PPP. On the 29th of September 2019, another meeting was organized in Madrid (during the ERS Congress) to also meet international pharmaceutical companies. More detailed information about the research proposal was presented there. On the 21st of January 2020 a Deep-dive meeting was organized for those organizations that committed to P4O2. During this meeting we shaped the proposal further and set clear deliverables.
If you are interested in joining the P4O2 consortium, please contact us at email@example.com. It is still possible to join the consortium also after it is started, so please contact us if you are interested in a call to discuss possibilities. P4O2 aims to stimulate collaboration in the field and between academic and private partners.